D
Pulmatrix, Inc. PULM
$6.14 -$0.525-7.88%
Recommendation
Sell
Prev Close
$7.19
Volume
42,036
Avg Vol (90D)
140,943
Market Cap
$26.26M
Dividend & Yield
--
52-Week Range
$1.68 - $10.40
P/E (TTM)
--
EPS (TTM)
-$2.62
My Lists My Alerts
Rating
Reward
E
Very Weak
Risk
D
Weak
Rating Factors
Growth Index
Good
Efficiency Index
Very Weak
Solvency Index
Good
Total Return Index
Fair
Volatility Index
Weak
Dividend Index
--
Headlines
Pulmatrix Reports 2024 Financials and Merger Plans
3/25/2025 - TipRanks Financial Blog
Pulmatrix Announces Year-End and Fourth Quarter 2024 Financial Results and Divestment Plan for ...
3/21/2025 - GuruFocus
Pulmatrix Announces Year-End and Fourth Quarter 2024 Financial Results and Divestment Plan for Assets
3/21/2025 - PR Newswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates TGI, PULM, CCNE, TURN on Behalf of Shareholders
2/25/2025 - PR Newswire
PULM Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Pulmatrix, Inc. ...
2/19/2025 - GuruFocus
PULM Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Pulmatrix, Inc. Is Fair to Shareholders
2/19/2025 - Business Wire
Pulmatrix (NASDAQ:PULM) Coverage Initiated by Analysts at StockNews.com
1/6/2025 - Ticker Report
Pulmatrix (NASDAQ:PULM) Now Covered by StockNews.com
12/29/2024 - Ticker Report
StockNews.com Begins Coverage on Pulmatrix (NASDAQ:PULM)
12/22/2024 - Ticker Report
StockNews.com Initiates Coverage on Pulmatrix (NASDAQ:PULM)
12/14/2024 - Ticker Report
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ROIC, BERY, PULM on Behalf of Shareholders
11/26/2024 - Globe Newswire
Kuehn Law Encourages BCOV, BERY, ROIC, and PULM Investors to Contact Law Firm
11/26/2024 - Globe Newswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CDE, ALVR, PULM, ENTO on Behalf of Shareholders
11/21/2024 - PR Newswire
Pulmatrix (NASDAQ:PULM) Research Coverage Started at StockNews.com
11/21/2024 - Ticker Report
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PULM, LBRDA, ENTO, LLYVA on Behalf of Shareholders
11/16/2024 - Globe Newswire
PULMATRIX INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Pulmatrix, Inc. - PULM
11/14/2024 - Business Wire
SHAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of Pulmatrix, Inc. PULM
11/14/2024 - Globe Newswire
Kuehn Law Encourages ENTO, PULM, PIK, and PFC Investors to Contact Law Firm
11/14/2024 - Globe Newswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PULM and ENTO on Behalf of Shareholders
11/14/2024 - Globe Newswire
Shareholder Alert: Ademi LLP investigates whether Pulmatrix, Inc. is obtaining a Fair Price for its Public Shareholders
11/14/2024 - Business Wire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AE, LBRDA, PULM, ENTO on Behalf of Shareholders
11/13/2024 - PR Newswire
PULM Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Pulmatrix, Inc. Is Fair to Shareholders
11/13/2024 - Business Wire
Pulmatrix trading resumes
11/13/2024 - TipRanks Financial Blog
Pulmatrix trading resumes
11/13/2024 - The Fly
Income Statement
Total Revenue (TTM)
$7.81M
EBITDA (TTM)
-$7.04M
EBIT (TTM)
-$7.15M
Net Income (TTM)
-$9.56M
Balance Sheet
Total Assets (Q)
$9.94M
Total Debt (Q)
$0.00
Total Liabilities (Q)
$996.00K
Book Value Per Share (Q)
$2.45
Cash Flow
Cash from Operations (TTM)
-$10.72M
Cash from Investing (TTM)
-$398.00K
Cash from Financing (TTM)
--
Net Change in Cash (TTM)
-$11.11M
Filings
Filing Date
Friday, March 21, 2025
Period Date
Tuesday, December 31, 2024
Next Filing
Week of May 5 and 9 (est)
Price History
Loading...
Beta
0.12
7-Day Total Return
-19.28%
30-Day Total Return
-20.63%
60-Day Total Return
-12.11%
90-Day Total Return
-6.48%
Year to Date Total Return
-19.80%
1-Year Total Return
252.59%
2-Year Total Return
113.76%
3-Year Total Return
-7.05%
5-Year Total Return
-72.11%
52-week Low
Apr 02, 2024 - $1.68
52-week High
Feb 18, 2025 - $10.40
Valuation
Market Cap
$26.26M - Nano Cap
Enterprise Value
$16.74M
Price/Sales (TTM)
2.62
Price/Book (Q)
2.40
Dividends and Shares
Shares Outstanding
3.65M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.pulmatrix.com
Phone Number
781 357 2333
Address
36 Crosby Drive
Bedford, MA 01730
Country
United States
Year Founded
2003
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Pulmatrix, Inc., a clinical stage biotechnology company, focused on development of novel inhaled therapeutic products to prevent and treat respiratory and other diseases with unmet medical needs... more
NASDAQ 04/01/2025 3:58PM Eastern Quotes delayed
Weiss Ratings